Yield10 Bioscience Probability of Future Stock Price Finishing Over 1.90
YTENDelisted Stock | USD 1.90 0.04 2.06% |
Yield10 |
Yield10 Bioscience Alerts and Suggestions
In today's market, stock alerts give investors the competitive edge they need to time the market and increase returns. Checking the ongoing alerts of Yield10 Bioscience for significant developments is a great way to find new opportunities for your next move. Suggestions and notifications for Yield10 Bioscience can help investors quickly react to important events or material changes in technical or fundamental conditions and significant headlines that can affect investment decisions.Yield10 Bioscience is not yet fully synchronised with the market data | |
Yield10 Bioscience may become a speculative penny stock | |
Yield10 Bioscience has a very high chance of going through financial distress in the upcoming years | |
The company reported the previous year's revenue of 60 K. Net Loss for the year was (14.46 M) with loss before overhead, payroll, taxes, and interest of (7.3 M). | |
Yield10 Bioscience currently holds about 10.16 M in cash with (10.07 M) of positive cash flow from operations. This results in cash-per-share (CPS) ratio of 2.07, which can makes it an attractive takeover target, given it will continue generating positive cash flow. | |
Roughly 13.0% of the company outstanding shares are owned by insiders |
Yield10 Bioscience Price Density Drivers
Market volatility will typically increase when nervous long traders begin to feel the short-sellers pressure to drive the market lower. The future price of Yield10 Stock often depends not only on the future outlook of the current and potential Yield10 Bioscience's investors but also on the ongoing dynamics between investors with different trading styles. Because the market risk indicators may have small false signals, it is better to identify suitable times to hedge a portfolio using different long/short signals. Yield10 Bioscience's indicators that are reflective of the short sentiment are summarized in the table below.
Common Stock Shares Outstanding | 331.1 K | |
Cash And Short Term Investments | 1.1 M |
Yield10 Bioscience Technical Analysis
Yield10 Bioscience's future price can be derived by breaking down and analyzing its technical indicators over time. Yield10 Stock technical analysis helps investors analyze different prices and returns patterns as well as diagnose historical swings to determine the real value of Yield10 Bioscience. In general, you should focus on analyzing Yield10 Stock price patterns and their correlations with different microeconomic environments and drivers.
Yield10 Bioscience Predictive Forecast Models
Yield10 Bioscience's time-series forecasting models is one of many Yield10 Bioscience's stock analysis techniques aimed to predict future share value based on previously observed values. Time-series forecasting models are widely used for non-stationary data. Non-stationary data are called the data whose statistical properties, e.g., the mean and standard deviation, are not constant over time, but instead, these metrics vary over time. This non-stationary Yield10 Bioscience's historical data is usually called time series. Some empirical experimentation suggests that the statistical forecasting models outperform the models based exclusively on fundamental analysis to predict the direction of the stock market movement and maximize returns from investment trading.
Things to note about Yield10 Bioscience
Checking the ongoing alerts about Yield10 Bioscience for important developments is a great way to find new opportunities for your next move. Our stock alerts and notifications screener for Yield10 Bioscience help investors to be notified of important events, changes in technical or fundamental conditions, and significant headlines that can affect investment decisions.
Yield10 Bioscience is not yet fully synchronised with the market data | |
Yield10 Bioscience may become a speculative penny stock | |
Yield10 Bioscience has a very high chance of going through financial distress in the upcoming years | |
The company reported the previous year's revenue of 60 K. Net Loss for the year was (14.46 M) with loss before overhead, payroll, taxes, and interest of (7.3 M). | |
Yield10 Bioscience currently holds about 10.16 M in cash with (10.07 M) of positive cash flow from operations. This results in cash-per-share (CPS) ratio of 2.07, which can makes it an attractive takeover target, given it will continue generating positive cash flow. | |
Roughly 13.0% of the company outstanding shares are owned by insiders |
Check out Your Current Watchlist to better understand how to build diversified portfolios. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as various price indices. You can also try the Analyst Advice module to analyst recommendations and target price estimates broken down by several categories.
Other Consideration for investing in Yield10 Stock
If you are still planning to invest in Yield10 Bioscience check if it may still be traded through OTC markets such as Pink Sheets or OTC Bulletin Board. You may also purchase it directly from the company, but this is not always possible and may require contacting the company directly. Please note that delisted stocks are often considered to be more risky investments, as they are no longer subject to the same regulatory and reporting requirements as listed stocks. Therefore, it is essential to carefully research the Yield10 Bioscience's history and understand the potential risks before investing.
Fundamental Analysis View fundamental data based on most recent published financial statements | |
Portfolio File Import Quickly import all of your third-party portfolios from your local drive in csv format | |
ETFs Find actively traded Exchange Traded Funds (ETF) from around the world | |
Technical Analysis Check basic technical indicators and analysis based on most latest market data | |
Instant Ratings Determine any equity ratings based on digital recommendations. Macroaxis instant equity ratings are based on combination of fundamental analysis and risk-adjusted market performance | |
Theme Ratings Determine theme ratings based on digital equity recommendations. Macroaxis theme ratings are based on combination of fundamental analysis and risk-adjusted market performance | |
Price Transformation Use Price Transformation models to analyze the depth of different equity instruments across global markets | |
Bonds Directory Find actively traded corporate debentures issued by US companies | |
Insider Screener Find insiders across different sectors to evaluate their impact on performance |